TECTONIC THERAPEUTIC, INC. Finance Lease, Weighted Average Discount Rate, Percent
TECTONIC THERAPEUTIC, INC. (TECX) had Finance Lease, Weighted Average Discount Rate, Percent of 10.24% as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent · last filed 2026-08-06
- 2026-06-30: Finance Lease, Weighted Average Discount Rate, Percent 10.24%.
- 2026-03-31: Finance Lease, Weighted Average Discount Rate, Percent 10.14%.
- 2025-12-31: Finance Lease, Weighted Average Discount Rate, Percent 1.03%.
- 2024-12-31: Finance Lease, Weighted Average Discount Rate, Percent 2.26%; Finance Lease, Weighted Average Discount Rate, Percent as first filed 9.76%.
| Period end | Finance Lease, Weighted Average Discount Rate, Percent | Finance Lease, Weighted Average Discount Rate, Percent as first filed |
|---|---|---|
| 2026-06-30 | 10.24% 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 10.14% 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 1.03% 10-K · filed 2026-02-26 | |
| 2024-12-31 | 2.26% 10-K · filed 2026-02-26 | 9.76% 10-K · filed 2025-03-20 |
| 2024-06-30 | 9.69% 10-Q · filed 2024-08-14 | |
| 2023-12-31 | 9.62% 10-K · filed 2025-03-20 | |
| 2023-06-30 | 9.58% 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |